Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EVAX Evaxion Biotech A/S

Pre-Mkt 05-21 05:22:26 EDT

4.00

+0.02

+0.50%

盘前3.90

-0.10-2.56%

04:11 EDT

High4.08	Low3.90	Vol14.65K
Open4.05	D1 Closing3.98	Amplitude4.52%
Mkt Cap33.21M	Tradable Cap22.13M	Total Shares8.30M
T/O58.12K	T/O Rate0.26%	Tradable Shares5.53M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EVAX","market":"US","secType":"STK","nameCN":"Evaxion Biotech A/S","latestPrice":4,"timestamp":1779307200000,"preClose":3.98,"halted":0,"volume":14654,"hourTrading":{"tag":"盘前","latestPrice":3.8975,"preClose":4,"latestTime":"04:11 EDT","volume":21,"amount":81.2474964,"timestamp":1779351113237,"change":-0.1025,"changeRate":-0.025625,"amplitude":0.009375},"delay":0,"changeRate":0.005025125628140708,"floatShares":5531900,"shares":8302700,"eps":-1.371838,"marketStatus":"Pre-Mkt","change":0.02,"latestTime":"05-21 05:22:26 EDT","open":4.05,"high":4.08,"low":3.9,"amount":58124.707065200004,"amplitude":0.045226,"askPrice":4.45,"askSize":100,"bidPrice":3.55,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.371838,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779370200000},"marketStatusCode":1,"adr":0,"adrRate":50,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":4,"preHourTrading":{"tag":"盘前","latestPrice":3.8975,"preClose":4,"latestTime":"04:11 EDT","volume":21,"amount":81.2474964,"timestamp":1779351113237,"change":-0.1025,"changeRate":-0.025625,"amplitude":0.009375},"postHourTrading":{"tag":"盘后","latestPrice":4.17,"preClose":4,"latestTime":"19:34 EDT","volume":259,"amount":1058.72,"timestamp":1779320071328,"change":0.17,"changeRate":0.0425,"amplitude":0.0425},"volumeRatio":0.4875143906694547,"impliedVol":2.1042,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/EVAX/tweets","defaultTab":"tweets","newsList":[{"id":"2636072182","title":"European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2636072182","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636072182?lang=en_us&edition=fundamental","pubTime":"2026-05-18 23:11","pubTimestamp":1779117088,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were heading higher late Monday morning, rising 0.88% to 1,825.10 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and healthcare tech company Royal Philips , which rose 4.6% and 2.9% respectively. They were followed by internet advertising firm Criteo  and biopharmaceutical company Grifols , which were up 2.8% each.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies  and biotech firm BioNTech , which dropped 3.2% and 2% respectively. They were followed by telecommunications company Nokia  and pharmaceutical company Ascendis Pharma , which were down 1.9% and 0.9% respectively.The gainers from the UK were led by biotech companies Autolus Therapeutics  and Trinity Biotech , which climbed 16% and 6.2% respectively. They were followed by communications company WPP  and educational publisher Pearson , which advanced 4.8% and 4.7","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LNOK","TRIB","BK4551","DBVT","BK4139","PHG","BK4505","BK4107","LU0320765992.SGD","BK4111","IEUR","IE00BFMHRM44.USD","PSO","MREO","BDRX","BK4082","BK4588","EVAX","CRTO","WPP","AMRN","BK4204","BK4117","BK4009","BK4535","BK4548","AUTL","BK4585","ASND","BK4568","NCNA","EPV","NOK","BK4020","WPP.AU","BNTX","BK4547","AFG","LU0109394709.USD","IE00BMPRXR70.SGD","LU0889565916.HKD","IE00BMPRXN33.USD","GRFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634091212","title":"Evaxion plans EVX-04 AML vaccine clinical trial application in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634091212","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634091212?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:31","pubTimestamp":1778592694,"startTime":"0","endTime":"0","summary":"Evaxion flagged new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine candidate for acute myeloid leukemia, scheduled for presentation at European Hematology Association Congress 2026.Results have not yet been presented; poster disclosure set for June 13, 2026, in Stockholm.Update is expected to outline functional characterization supporting EVX-04’s development rationale, positioning program for move toward first clinical testing.Clinical trial application planned for second half of 2026, marking next major value inflection for asset.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL29Tbz7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634357217","title":"Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2634357217","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634357217?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:30","pubTimestamp":1778592600,"startTime":"0","endTime":"0","summary":"Data will reflect the functional characterization of EVX-04Poster presentation on June 13, 2026 COPENHAGEN, Denmark, May 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293006/0/en/Evaxion-to-present-new-data-for-EVX-04-an-off-the-shelf-therapeutic-vaccine-for-acute-myeloid-leukemia-at-the-EHA-2026-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4528","BK4585","CHAT","BK4588","BK4587","EVX","AI","AIPO","BK4023","BK4543","BK4551","ARTY","AGIX","BK4139","EVAX","AIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634007804","title":"Evaxion Biotech (EVAX) Gets a Buy from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2634007804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634007804?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:38","pubTimestamp":1778495918,"startTime":"0","endTime":"0","summary":"In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Evaxion Biotech, with a price target of $16.00. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evaxion-biotech-evax-gets-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evaxion-biotech-evax-gets-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","EVAX","BK4139","XBI","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634427329","title":"Evaxion Biotech Signals Strong R&D Momentum Amid Cash Constraints","url":"https://stock-news.laohu8.com/highlight/detail?id=2634427329","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634427329?lang=en_us&edition=fundamental","pubTime":"2026-05-11 08:09","pubTimestamp":1778458186,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S Adr (($EVAX)) has held its Q1 earnings call. Read on for the main highlights of the call. Evaxion Biotech’s latest earnings cal...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-signals-strong-rd-momentum-amid-cash-constraints?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-signals-strong-rd-momentum-amid-cash-constraints?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4139","EVAX","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634467257","title":"Michael Okunewitch Initiates Buy on Evaxion, Citing Strong Clinical Data, AI-Driven Vaccine Platform, and Cash Runway to 2H 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2634467257","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634467257?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:15","pubTimestamp":1778274921,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Michael Okunewitch has maintained their bullish stance on EVAX stock, giving a Buy rating today. Michael Okunewitch has given h...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/michael-okunewitch-initiates-buy-on-evaxion-citing-strong-clinical-data-ai-driven-vaccine-platform-and-cash-runway-to-2h-2027-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/michael-okunewitch-initiates-buy-on-evaxion-citing-strong-clinical-data-ai-driven-vaccine-platform-and-cash-runway-to-2h-2027-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHAT","AIPO","ARTY","AGIX","BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634029465","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2634029465","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634029465?lang=en_us&edition=fundamental","pubTime":"2026-05-09 01:10","pubTimestamp":1778260212,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Evaxion Biotech (EVAX), Zura Bio (ZURA) and Argenx S...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-157?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-157?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX","LU0128526141.USD","LU0029874061.USD","BK4137","ZURA","ARGX","BK4581","BK4585","BLSX","LABU","BLSG","XBI","BK4139","BK4112","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633502674","title":"European Equities Traded in the US as American Depositary Receipts Rise Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2633502674","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633502674?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:10","pubTimestamp":1778253004,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were higher late Friday morning, rising 0.78% to 1,826.25 on the S&P Europe Select ADR Index, which is up 1.3% for the week so far.From continental Europe, the gainers were led by telecommunications company Nokia  and biotech firm Evaxion , which rose 4.7% and 4.4% respectively. They were followed by oil and gas company Eni  and lender Banco Bilbao Vizcaya Argentaria , which increased 2.6% and 2.5% respectively.The decliners from continental Europe were led by software firm SAP  and semiconductor firm Sequans Communications , which fell 1.6% and 1.2% respectively. They were followed by biopharmaceutical company DBV Technologies  and internet browser company Opera , which were off 1% and 0.9% respectively.The gainers from the UK were led by Lloyds Banking Group , which rose 3%. It was followed by telecommunications operator Vodafone Group  and InterContinental Hotels Group , which were up 2.7% and 2.6% respectively.The d","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BMPRXR70.SGD","BK4107","IHG","IEUR","SQNS","BK4547","BK4142","LNOK","BK4521","BK4201","VOD","PSO","LU0648005311.SGD","BK4585","BK4117","DBVT","BK4204","DAVA","DAVA.AU","SNN","BK4082","BK4111","LYG","BDRX","BK4528","BK4207","LU0084288595.USD","BK4141","EPV","OPRA","IE00BMPRXN33.USD","SAP","BK4132","BK4532","EVAX","E","BK4134","AFG","BK4020","BK4588","BK4023","BK4613","NOK","BBVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633128229","title":"Evaxion A/S reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633128229","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633128229?lang=en_us&edition=fundamental","pubTime":"2026-05-07 21:33","pubTimestamp":1778160783,"startTime":"0","endTime":"0","summary":"Evaxion A/S reports results for the quarter ended March 31 - Earnings SummaryEvaxion A/S EVAX.OQ reported a quarterly adjusted loss of 50 cents per share for the quarter ended March 31, identical to t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL8N41K1QR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149030","title":"Denmark's Evaxion Q1 net loss widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149030","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149030?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:43","pubTimestamp":1778154186,"startTime":"0","endTime":"0","summary":"Denmark's Evaxion Q1 net loss widensOverviewDenmark vaccine developer reported Q1 net loss widened yr/yrQ1 net loss increased due to lower financial income from derivative remeasurementCompany maintai","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL1N41K0OE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149869","title":"BRIEF-Evaxion Q1 Basic EPS USD -0.01","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149869","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149869?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153447,"startTime":"0","endTime":"0","summary":"BRIEF-Evaxion Q1 Basic EPS USD -0.01\n\n\nMay 07 (Reuters) - Evaxion Q1 net income USD -3.629 million.\n\nQ1 pretax profit USD -3.845 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX284870:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633514677","title":"Evaxion Q1 Pretax Profit USD -3.845 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633514677","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633514677?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX284870:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633047146","title":"Evaxion Q1 Net Income USD -3.629 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633047146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633047146?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX284870:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633146011","title":"Evaxion Announces Business Update and First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633146011","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633146011?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA2JG9RF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149316","title":"Press Release: Evaxion announces business update and first quarter 2026 financial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149316","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149316?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153400,"startTime":"0","endTime":"0","summary":"COPENHAGEN, Denmark, May 7, 2026 - Evaxion A/S  , a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology platform, provides business update and announces first quarter 2026 financial results.Evaxion has had a good start to the year executing on our plans and achieving our first milestone for 2026 as expected. Highlights include:. -- New data demonstrating an 86% vaccine target recognition by. AI-Immunology in personalized cancer vaccine EVX-01 is a further. scientific validation of the platform's precision in driving immune. response. This marked our first milestone for the year. -- Another new set of data confirming the platform's unique scalability in. -- Successful completion of the one-year extension of our phase 2 trial with. EVX-01 paving the way for presentation of three-year clinical data in the. EVX-01 is our most advanced asset. Developed with AI-Immunology, i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","CHAT","BK4587","BK4023","BK4588","EVAX","BK4585","03160","AI","BK4604","BK4139","AIYY","AIPO","BK4555","TM","BK4528","BK4099","ARTY","BK4551","BK4543"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633945947","title":"Evaxion A/S  expected to post a loss of 30 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633945947","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633945947?lang=en_us&edition=fundamental","pubTime":"2026-05-05 21:20","pubTimestamp":1777987206,"startTime":"0","endTime":"0","summary":"Evaxion A/S  expected to post a loss of30cents a share - Earnings Preview Evaxion A/S EVAX.OQ EVAX.O is expected to  show no change in quarterly revenue when it reports  results on May 7 for the perio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I1SA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632584939","title":"Evaxion to report Q1 results, host business update call","url":"https://stock-news.laohu8.com/highlight/detail?id=2632584939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632584939?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:01","pubTimestamp":1777896088,"startTime":"0","endTime":"0","summary":"Evaxion schedules first-quarter 2026 financial results release for May 7, 2026, ahead of Nasdaq CM open.Business update presentation set for May 7 at 14:30 CET/08:30 EST via conference call and webcast, with Q&A.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDLsnFbJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2095319765.USD","BK4585","IE00BN0W2W23.USD","IE00BGHQF748.EUR","LU2210149790.SGD","SG9999014005.SGD","BK4588","LU2210150020.SGD","LU0314104364.USD","NDAQ","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","SG9999014013.SGD","BK4139","BK4112","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014039.USD","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632395817","title":"Press Release: Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2632395817","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632395817?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:00","pubTimestamp":1777896000,"startTime":"0","endTime":"0","summary":"Evaxion's Executive Management will host a conference call and webcast the same day at 14:30 CET/08:30 EST, presenting the update and results as well as taking questions.To join the conference call, listen to the presentation and ask verbal questions, please register in advance via this link to receive the dial-in telephone numbers and a unique PIN code. The call can be accessed 15 minutes prior to the start of the live event.To join the webcast, please click on this link. The webcast recording will be available on our website shortly after the event.Evaxion is a pioneering TechBio company based upon its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases.With AI-Immunology we conduct rapid, efficient and high-quality target discovery, drug design and development. Our team of +40 experts covers the e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","BK4588","AIPO","BK4604","AGIX","BK4555","BK4528","CHAT","TM","BK4139","BK4585","03160","BK4587","BK4099","ARTY","EVAX","BK4023","AIYY","AI","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630391166","title":"BRIEF-Evaxion Promotes Birgitte Rønø To Joint Role Of Chief Scientific And Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2630391166","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630391166?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:48","pubTimestamp":1777294096,"startTime":"0","endTime":"0","summary":"BRIEF-Evaxion Promotes Birgitte Rn To Joint Role Of Chief Scientific And Chief Operating OfficerApril 27 (Reuters) - Evaxion A/S EVAX.O:EVAXION PROMOTES BIRGITTE RN TO JOINT ROLE OF CHIEF SCIENTIFIC A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA4XSXVD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630939654","title":"Evaxion Promotes Birgitte RØNØ to Joint Role of Chief Scientific and Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2630939654","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630939654?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:00","pubTimestamp":1777291204,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA4XSXVD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evaxion.ai","stockEarnings":[{"period":"1week","weight":-0.0385},{"period":"1month","weight":-0.1091},{"period":"3month","weight":0.1494},{"period":"6month","weight":-0.2278},{"period":"1year","weight":1.2857},{"period":"ytd","weight":-0.1614}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.0459},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.2503},{"period":"ytd","weight":0.087}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.312391},{"month":2,"riseRate":0,"avgChangeRate":-0.075072},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.067423},{"month":4,"riseRate":0.666667,"avgChangeRate":0.093874},{"month":5,"riseRate":0.333333,"avgChangeRate":0.041103},{"month":6,"riseRate":0.2,"avgChangeRate":-0.044814},{"month":7,"riseRate":0.4,"avgChangeRate":0.060856},{"month":8,"riseRate":0.6,"avgChangeRate":-0.04913},{"month":9,"riseRate":1,"avgChangeRate":0.19717},{"month":10,"riseRate":0.4,"avgChangeRate":0.102065},{"month":11,"riseRate":0.2,"avgChangeRate":-0.236379},{"month":12,"riseRate":0,"avgChangeRate":-0.21322}],"exchange":"NASDAQ","name":"Evaxion Biotech A/S","nameEN":"Evaxion Biotech A/S","securityTypeName":"DR","adrRate":"1:50"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evaxion Biotech A/S,EVAX,Evaxion Biotech A/S股票,Evaxion Biotech A/S股票老虎,Evaxion Biotech A/S股票老虎国际,Evaxion Biotech A/S行情,Evaxion Biotech A/S股票行情,Evaxion Biotech A/S股价,Evaxion Biotech A/S股市,Evaxion Biotech A/S股票价格,Evaxion Biotech A/S股票交易,Evaxion Biotech A/S股票购买,Evaxion Biotech A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction